Renal and urinary disorders

Disease1 paper1 finding

In silico1

Associations

1

SGLT-2 inhibitor + metformin

upin humans1Low certainty

1 study

SGLT-2 inhibitor + metformin is associated with renal and urinary disorders in humans (ROR = 3.91).
Humanspharmacovigilance disproportionality analysis
Adverse event reporting signals for SGLT-2 inhibitor-metformin combination therapy: a disproportionality analysis of the FAERS database · Frontiers in endocrinology · 4 Sep 2026

SGLT-2 inhibitor + metformin →

Latest

1

Frontiers in EndocrinologyIn silico19 Sep

Adverse event reporting signals for SGLT-2 inhibitor-metformin combination therapy: a disproportionality analysis of the FAERS database

SGLT2 inhibitors